Sign Up

To receive our monthly eNews as well as event notices and other updates, just enter your email address.

   Please leave this field empty
  

Stay Connected
to NYAM

Take a moment to learn more about NYAM's activities and events.

NYAM to Partner on Major Global Research Initiative on Diabetic Retinopathy

View the full partnership statement

The New York Academy of Medicine (NYAM) is pleased to announce its collaboration with the International Federation on Ageing (IFA), International Diabetes Federation (IDF), and International Agency for the Prevention of Blindness (IABP) to assess the global awareness, treatment, and implications of diabetic retinopathy, a common and serious complication of diabetes. View the full partnership statement.

Across the course of the Global Reseach Initiative on Diabetic Retinopathy evidence on knowledge, policies, standards of care, and supportive services for retinopathy will be gathered across 40 countries in order to inform clinical practice and policy development to improve the prevention and management of this disease.

“Given the scale of the diabetes epidemic worldwide, and the devastating impacts of vision loss, we are very pleased to be part of this important collaboration, which has the potential to improve policy and practice globally,” said Dr. Linda Weiss, Director of the Center for Evaluation and Applied Research.

NYAM’s Center for Evaluation and Applied Research and the Center for Health Innovation are conducting the research, including surveys, interviews, literature reviews, and projections of disease burden, that will form the basis of the project reports, policy recommendations, and other resources to be developed through this collaboration.

“NYAM is uniquely positioned to conduct this type of important research related to the prevention and treatment of chronic diseases, such as diabetic retinopathy.  Focusing on individuals and their broader communities helps us translate the research into policy that reduces the global burden of disease and disability”, said Dr. David Siscovick, NYAM Senior Vice President for Research.

The study is funded by Bayer Pharma AG; Bayer will not be involved in analysis of study findings.

 Print   Subscribe

 

Posted on May 12, 2014

Contact:
Gina Ravosa
Director of Marketing & Communications
The New York Academy of Medicine
1216 Fifth Avenue
New York, NY 10029
(212) 822-7285
gravosa@nyam.org

 

More NYAM News Articles

Contact NYAM Experts

Reporters: to arrange interviews with NYAM medical and urban health experts, contact
Gina Ravosa, Director of Marketing & Communications

(212) 822-7285 / gravosa@nyam.org

The 2013 Duncan Clark Lecture - The Affordable Care Act on the Verge of Final Success ... and a Nervous Breakdown

The 2013 Duncan Clark Lecture - The Affordable Care Act on the Verge of Final Success ... and a Nervous Breakdown

Featured Speaker: John E. McDonough, DPH, MPA, Professor of the Practice of Public Health and Director of the Center for Public Health Leadership 
Department of Health Policy and Management at the Harvard School of Public Health

December 9, 2013 - On December 2, 2013 NYAM welcomed Dr. John E. McDonough, one of the leading experts on health care reform in the United States, to deliver the 2013 Duncan Clark Lecture at NYAM on “The Affordable Care Act on the Verge of Final Success ... and a Nervous Breakdown.”
Learn more »

NYAM Report - Federal Health Care Reform in New York State: A Population Health Perspective

The New York Academy of Medicine with support from the New York State Heath Foundation released a new report, Federal Health Care Reform in New York State: A Population Health Perspective.

This report identifies opportunities that build on both the Patient Protection and Affordable Health Care Act (ACA) and New York’s ongoing efforts toward improving the health of its 19 million residents.

Read press release

Read report

More NYAM publications »

Powered by Convio
nonprofit software